Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

TomoTherapy narrows losses in Q3

TomoTherapy, a developer of radiation therapy technologies for cancer care, has announced its financial results for the third quarter, which ended Sept. 30, indicating a decrease in net losses.

Mass General chooses RayStation software for radiation treatment

Massachusetts General Hospital in Boston has chosen RaySearch Laboratories' RayStation treatment planning software to optimize radiation therapy doses.

JNCI: Breast density, no lobular involution raise cancer risk

Women with dense breasts and no lobular involution may face significantly higher risks of developing breast cancer, according to a study published in the Journal of the National Cancer Institute.

AAFP to Berwick: Re-evaluate RUC

The dependence on the use of Relative Value Scale Update Committees (RUC) needs to be re-evaluated and more focus should be placed in primary care, Lori Heim, MD, board chair of the American Academy of Family Physicians (AAFP), wrote to Donald Berwick, MD, the administrator of the Centers for Medicare & Medicaid Services (CMS), in a letter dated Oct. 8.

NIH unveils Images database

More than 2.5 million images and figures from medical and life sciences journals are now available through Images, a new resource for finding images in biomedical literature. The database was developed and will be maintained by the National Center for Biotechnology Information, a division of the National Library of Medicine at the National Institutes of Health (NIH).

ASTRO: Chemo-radiotherapy may sub for bladder cancer surgery

The addition of chemotherapy to radiation therapy in patients with bladder cancer significantly reduced recurrence of the disease, according to a study that will be presented Nov. 1 at the annual meeting for the American Society of Radiation Oncology (ASTRO) in San Diego.

ASTRO: RT + hormone therapy improves prostate cancer survival

Patients with prostate cancer who are treated with radiation therapy in addition to hormone therapy have significantly higher chances of survival than patients treated with hormone therapy alone, according to a study that will be presented Nov. 1 at the Annual Meeting of the American Society of Radiation Oncology (ASTRO) in San Diego.

South Africa provider to study Calypso RT transponders in lung

A hospital in Cape Town, South Africa, has initiated a clinical trial in which Calypso Medical Technologies' Beacon transponders were implanted into the lung to track lung tumors and focus radiotherapy on the moving tumors.

Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.